LGALS3 and diabetes mellitus: Elevated pro-collagen type III amino-terminal peptide and galectin-3 levels were associated with an increased risk of the primary outcome (cardiovascular mortality, aborted cardiac arrest, or HF hospitalization) in DM patients, but not in those without diabetes (De Marco et al., 2021[21]).